Registration of systematic reviews in PROSPERO: 30,000 records and counting

Systematic Reviews

Volumn 7, Issue 1, 2018, Pages

  Page, Matthew J ^a   Shamseer, Larissa ^b,c   Tricco, Andrea C ^d,e  

^a MONASH UNIVERSITY   (Australia)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Methodology; Quality; Registration; Reporting; Systematic reviews

Indexed keywords

ARTICLE; BEHAVIOR DISORDER; CONNECTIVE TISSUE; EYE; HUMAN; ICD-10; MENTAL DISEASE; MUSCULOSKELETAL SYSTEM; PRIORITY JOURNAL; REGISTRATION; SCIENTIFIC LITERATURE; SYSTEMATIC REVIEW; BIBLIOMETRICS; PUBLICATION;

BIBLIOMETRICS; HUMANS; PUBLICATIONS; SYSTEMATIC REVIEWS AS TOPIC;

EID: 85042553271     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-018-0699-4     Document Type: Article

References (41)

1. Page MJ, Shamseer L, Altman DG, Tetzlaff J, Sampson M, Tricco AC, et al. Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study. PLoS Med. 2016;13(5):e1002028.
2. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med. 2007;4:e78.
3. Stewart L, Moher D, Shekelle P. Why prospective registration of systematic reviews makes sense. Syst Rev. 2012;1:7.
4. Moher D, Booth A, Stewart L. How to reduce unnecessary duplication: use PROSPERO. BJOG. 2014;121(7):784-6.
5. Page MJ, Altman DG, Shamseer L, McKenzie JE, Ahmadzai N, Wolfe D, et al. Reproducible research practices are underused in systematic reviews of biomedical interventions. J Clin Epidemiol. 2018;94:8-18.
6. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
7. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
8. Tricco AC, Pham B, Brehaut J, Tetroe J, Cappelli M, Hopewell S, et al. An international survey indicated that unpublished systematic reviews exist. J Clin Epidemiol. 2009;62(6):617-23. e5
9. Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS One. 2010;5(3):e9810.
10. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1:2.
11. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet. 2011;377(9760):108-9.
12. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. Establishing a minimum dataset for prospective registration of systematic reviews: an international consultation. PLoS One. 2011;6(11):e27319.
13. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. PROSPERO at one year: an evaluation of its utility. Syst Rev. 2013;2:4.
14. Tricco AC, Cogo E, Page MJ, Polisena J, Booth A, Dwan K, et al. A third of systematic reviews changed or did not specify the primary outcome: a PROSPERO register study. J Clin Epidemiol. 2016;79:46-54.
15. Borah R, Brown AW, Capers PL, Kaiser KA. Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry. BMJ Open. 2017;7(2):e012545.
16. Sideri S, Papageorgiou SN, Eliades T. Are orthodontic systematic reviews registered a priori in PROSPERO? J Orthod. 2017;44(4):249-55.
17. Page MJ, McKenzie JE, Chau M, Green SE, Forbes A. Methods to select results to include in meta-analyses deserve more consideration in systematic reviews. J Clin Epidemiol. 2015;68(11):1282-91.
18. Liu Z, Saldanha IJ, Margolis D, Dumville JC, Cullum NA. Outcomes in Cochrane systematic reviews related to wound care: an investigation into prespecification. Wound Repair Regen. 2017;25(2):292-308.
19. Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, et al. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Cochrane Database Syst Rev. 2014;10:MR000035.
20. Saldanha IJ, Dickersin K, Wang X, Li T. Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability. PLoS One. 2014;9(10):e109400.
21. StataCorp. Stata statistical software: release 14. College Station: StataCorp LP; 2015.
22. Page MJ, Forbes A, Chau M, Green SE, McKenzie JE. Investigation of bias in meta-analyses due to selective inclusion of trial effect estimates: empirical study. BMJ Open. 2016;6(4):e011863.
23. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med. 2004;351(12):1250-1.
24. Nosek BA, Alter G, Banks GC, Borsboom D, Bowman SD, Breckler SJ, et al. Scientific standards. Promoting an open research culture. Science. 2015;348(6242):1422-5.
25. McKiernan EC, Bourne PE, Brown CT, Buck S, Kenall A, Lin J, et al. How open science helps researchers succeed. elife. 2016;5:e16800.
26. Kidwell MC, Lazarevic LB, Baranski E, Hardwicke TE, Piechowski S, Falkenberg LS, et al. Badges to acknowledge open practices: a simple, low-cost, effective method for increasing transparency. PLoS Biol. 2016;14(5):e1002456.
27. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
28. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
29. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. Available from http://training.cochrane.org/handbook.
30. Tricco AC, Zarin W, Ghassemi M, Nincic V, Lillie E, Page MJ, et al. Same family, different species: methodological conduct and quality varies according to purpose for five types of knowledge synthesis. J Clin Epidemiol. 2017.
31. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095-128.
32. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1151-210.
33. Yoong SL, Hall A, Williams CM, Skelton E, Oldmeadow C, Wiggers J, et al. Alignment of systematic reviews published in the Cochrane database of systematic reviews and the database of abstracts and reviews of effectiveness with global burden-of-disease data: a bibliographic analysis. J Epidemiol Community Health. 2015;69(7):708-14.
34. Schuit E, Ioannidis JP. Network meta-analyses performed by contracting companies and commissioned by industry. Systematic Reviews. 2016;5(1):198.
35. Mayo-Wilson E, Fusco N, Li T, Hong H, Canner JK, Dickersin K. Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis. J Clin Epidemiol. 2017;86:39-50.
36. Mayo-Wilson E, Li T, Fusco N, Bertizzolo L, Canner JK, Cowley T, et al. Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy. J Clin Epidemiol. 2017. J Clin Epidemiol. 2017;91:95-110.
37. Tricco AC, Lillie E, Zarin W, O'Brien K, Colquhoun H, Kastner M, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016;16:15.
38. Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, et al. Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol. 2017;91:23-30.
39. Abou-Setta AM, Jeyaraman MM, Attia A, Al-Inany HG, Ferri M, Ansari MT, et al. Methods for developing evidence reviews in short periods of time: a scoping review. PLoS One. 2016;11(12):e0165903.
40. Ioannidis JP. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. The Milbank Quarterly. 2016;94(3):485-514.
41. Page MJ, Moher D. Mass production of systematic reviews and meta-analyses: an exercise in mega-silliness? The Milbank Quarterly. 2016;94(3):515-9.